Package 49702-231-13

Brand: triumeq

Generic: abacavir sulfate, dolutegravir sodium, lamivudine
NDC Package

Package Facts

Identity

Package NDC 49702-231-13
Digits Only 4970223113
Product NDC 49702-231
Description

30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)

Marketing

Marketing Status
Marketed Since 2014-08-22
Brand triumeq
Generic abacavir sulfate, dolutegravir sodium, lamivudine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4018a8c7-db0d-481e-b50a-a469ba32ec4b", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0349702231139"], "unii": ["J220T4J9Q2", "1Q1V9V5WYQ", "2T8Q726O95"], "rxcui": ["1546888", "1546894", "2598348", "2598352"], "spl_set_id": ["2997739a-aa91-42aa-a206-a70e2db7b84f"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)", "package_ndc": "49702-231-13", "marketing_start_date": "20140822"}], "brand_name": "Triumeq", "product_id": "49702-231_4018a8c7-db0d-481e-b50a-a469ba32ec4b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "HIV Integrase Inhibitors [MoA]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "49702-231", "generic_name": "abacavir sulfate, dolutegravir sodium, lamivudine", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triumeq", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "600 mg/1"}, {"name": "DOLUTEGRAVIR SODIUM", "strength": "50 mg/1"}, {"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "NDA205551", "marketing_category": "NDA", "marketing_start_date": "20140822", "listing_expiration_date": "20271231"}